| Identification | Back Directory | [Name]
Thieno[3,2-g]quinoline-6-carboxamide, 2-amino-3-cyano-N-[[[2-(dimethylamino)ethyl]amino]carbonyl]-4,4a,5,6,7,8,8a,9-octahydro-8-methyl-N-propyl-, (4aR,6R,8aR)- | [CAS]
1399442-97-7 | [Synonyms]
Thieno[3,2-g]quinoline-6-carboxamide, 2-amino-3-cyano-N-[[[2-(dimethylamino)ethyl]amino]carbonyl]-4,4a,5,6,7,8,8a,9-octahydro-8-methyl-N-propyl-, (4aR,6R,8aR)- | [Molecular Formula]
C22H34N6O2S | [MOL File]
1399442-97-7.mol | [Molecular Weight]
446.61 |
| Hazard Information | Back Directory | [Uses]
Matsupexolum (Matsupexole) is a dopamine receptor agonist[1]. | [References]
[1] Matsupexolum (Matsupexole). WHO Drug Information, Vol. 37, No. 4, 2023. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|